The third cluster (blue, 124 items) centers on inflammation-related pathways and specific pathological conditions, incorporating both molecular mediators (Nrf2, NLRP3, HMGB1) and disease states (atherosclerosis, ulcerative colitis, liver diseases). Here, HMGB1 is linked to liver disorder.